Skip to Main Navigation
Skip to Page Content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Share This:
https://ntp.niehs.nih.gov/go/9108

TDMS Study 92012-05 Pathology Tables

NTP Experiment-Test: 92012-05         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                         2-METHYLIMIDAZOLE                                     Date: 03/14/03
Route: DOSED FEED                                                                                                 Time: 10:29:56

                                                      FINAL#1; REVISION #1




       Facility:  Southern Research Institute

       Chemical CAS #:  693-98-1

       Lock Date:  10/16/01

       Cage Range:  All

       Reasons For Removal:    25019 Moribund Sacrifice                25020 Natural Death
                               25021 Terminal Sacrifice

       Removal Date Range:     All

       Treatment Groups:       Include All

































a  Number of animals examined microscopically at site and number of animals with lesion

                                                              Page   1


NTP Experiment-Test: 92012-05         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: CHRONIC                                         2-METHYLIMIDAZOLE                                     Date: 03/14/03    
Route: DOSED FEED                                                                                                 Time: 10:29:56    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         FISCHER 344 RATS FEMALE                   0PPM         1000 PPM     2500 PPM     5000 PPM                                  
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
DISPOSITION SUMMARY                                                                                                                 
                                                                                                                                    
  Animals Initially In Study                          60           60           60           60                                     
  Early Deaths                                                                                                                      
    Natural Death                                      4            3           10            1                                     
    Moribund Sacrifice                                 6            8           12            7                                     
  Survivors                                                                                                                         
    Terminal Sacrifice                                40           39           28           41                                     
    Natural Death                                                                             1                                     
                                                                                                                                    
  Animals Examined Microscopically                    50           50           50           50                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ALIMENTARY SYSTEM                                                                                                                  
                                                                                                                                    
   Intestine Large, Cecum                             (48)         (47)         (44)         (50)                                   
      Edema                                                                                   1 (2%)                                
   Intestine Small, Jejunum                           (47)         (46)         (44)         (49)                                   
      Necrosis, Focal                                                                         1 (2%)                                
   Liver                                              (50)         (49)         (50)         (50)                                   
      Angiectasis, Focal                               2 (4%)       1 (2%)       2 (4%)                                             
      Basophilic Focus                                42 (84%)     44 (90%)     43 (86%)     39 (78%)                               
      Cholangiofibrosis                                                                       1 (2%)                                
      Congestion                                                                 2 (4%)       1 (2%)                                
      Congestion, Focal                                                          1 (2%)                                             
      Degeneration, Cystic, Focal                                   1 (2%)                    2 (4%)                                
      Eosinophilic Focus                                                         1 (2%)                                             
      Fatty Change                                                  2 (4%)       1 (2%)                                             
      Hemorrhage                                       2 (4%)                                 2 (4%)                                
      Hepatodiaphragmatic Nodule                       6 (12%)     11 (22%)     14 (28%)     13 (26%)                               
      Hyperplasia, Focal, Lymphoid                                               1 (2%)       1 (2%)                                
      Infarct                                                                                 2 (4%)                                
      Infiltration Cellular, Mixed Cell               42 (84%)     44 (90%)     34 (68%)     38 (76%)                               
      Inflammation, Granulomatous                     18 (36%)     23 (47%)     22 (44%)     42 (84%)                               
      Mixed Cell Focus                                15 (30%)     14 (29%)     11 (22%)     26 (52%)                               
      Necrosis, Focal                                               1 (2%)                    1 (2%)                                
      Bile Duct, Cholangiofibrosis, Focal                                        1 (2%)                                             
      Bile Duct, Cyst                                  2 (4%)                                                                       
      Bile Duct, Cyst, Multiple                                                  1 (2%)       1 (2%)                                
      Bile Duct, Hyperplasia                          20 (40%)     29 (59%)     20 (40%)     40 (80%)                               
      Hepatocyte, Necrosis, Focal                                                1 (2%)       2 (4%)                                
      Hepatocyte, Vacuolization Cytoplasmic, Focal     9 (18%)     10 (20%)     11 (22%)      9 (18%)                               
      Hepatocyte, Periportal, Vacuolization                                                                                         
        Cytoplasmic                                                              1 (2%)                                             
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                             Page    2                                                              
                                                                                                                                   
NTP Experiment-Test: 92012-05         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: CHRONIC                                         2-METHYLIMIDAZOLE                                     Date: 03/14/03    
Route: DOSED FEED                                                                                                 Time: 10:29:56    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         FISCHER 344 RATS FEMALE                   0PPM         1000 PPM     2500 PPM     5000 PPM                                  
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ALIMENTARY SYSTEM - CONT                                                                                                            
      Hepatocyte, Centrilobular, Necrosis                                        1 (2%)       1 (2%)                                
      Hepatocyte, Centrilobular, Vacuolization                                                                                      
        Cytoplasmic                                    1 (2%)                    4 (8%)       1 (2%)                                
   Mesentery                                          (8)          (10)         (12)         (9)                                    
      Fibrosis                                                      1 (10%)                                                         
      Hemorrhage, Focal                                                                       1 (11%)                               
      Infiltration Cellular, Mixed Cell                                          1 (8%)                                             
      Inflammation, Chronic                                         1 (10%)                                                         
      Artery, Inflammation, Chronic, Focal                                                    1 (11%)                               
      Fat, Necrosis                                                 1 (10%)      2 (17%)                                            
      Fat, Necrosis, Focal                             5 (63%)      7 (70%)      6 (50%)      3 (33%)                               
   Pancreas                                           (50)         (49)         (49)         (50)                                   
      Infiltration Cellular, Diffuse, Mixed Cell                    1 (2%)                                                          
      Acinus, Atrophy, Diffuse                         1 (2%)       1 (2%)                    1 (2%)                                
      Acinus, Atrophy, Focal                          13 (26%)     14 (29%)     13 (27%)     11 (22%)                               
      Duct, Cyst, Focal                                1 (2%)                                 1 (2%)                                
      Duct, Cyst, Focal, Multiple                      9 (18%)     12 (24%)      4 (8%)       5 (10%)                               
   Salivary Glands                                    (50)         (49)         (50)         (50)                                   
      Duct, Mineralization, Focal                                                             2 (4%)                                
   Stomach, Forestomach                               (50)         (50)         (50)         (50)                                   
      Diverticulum                                     1 (2%)       1 (2%)                    2 (4%)                                
      Edema                                                                                   1 (2%)                                
      Erosion                                                                    1 (2%)                                             
      Inflammation, Chronic                                         1 (2%)       1 (2%)                                             
      Inflammation, Focal                                                        1 (2%)                                             
      Ulcer                                                         2 (4%)       1 (2%)       1 (2%)                                
      Epithelium, Hyperplasia                          3 (6%)       1 (2%)       4 (8%)       1 (2%)                                
   Stomach, Glandular                                 (49)         (49)         (48)         (50)                                   
      Erosion                                                       1 (2%)       1 (2%)                                             
      Inflammation, Chronic                                                      1 (2%)                                             
      Necrosis, Focal                                                            1 (2%)                                             
      Ulcer                                            1 (2%)                                                                       
      Epithelium, Hyperplasia, Focal                   1 (2%)                                                                       
      Glands, Degeneration, Cystic, Focal                                        1 (2%)                                             
      Glands, Ectasia, Focal                           1 (2%)                                                                       
      Glands, Hyperplasia, Focal                                                              2 (4%)                                
   Tongue                                             (3)                       (1)                                                 
      Epithelium, Hyperplasia, Focal                   1 (33%)                                                                      
   Tooth                                              (1)                                                                           
      Peridontal Tissue, Inflammation, Chronic         1 (100%)                                                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                                                                                                    
                                                             Page    3                                                              
                                                                                                                                   
NTP Experiment-Test: 92012-05         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: CHRONIC                                         2-METHYLIMIDAZOLE                                     Date: 03/14/03    
Route: DOSED FEED                                                                                                 Time: 10:29:56    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         FISCHER 344 RATS FEMALE                   0PPM         1000 PPM     2500 PPM     5000 PPM                                  
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 CARDIOVASCULAR SYSTEM                                                                                                              
                                                                                                                                    
   Heart                                              (50)         (49)         (50)         (50)                                   
      Cardiomyopathy                                   5 (10%)      8 (16%)      7 (14%)      6 (12%)                               
      Infiltration Cellular, Mixed Cell                             4 (8%)       3 (6%)       2 (4%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ENDOCRINE SYSTEM                                                                                                                   
                                                                                                                                    
   Adrenal Cortex                                     (50)         (49)         (50)         (50)                                   
      Accessory Adrenal Cortical Nodule                2 (4%)       2 (4%)       5 (10%)      5 (10%)                               
      Angiectasis                                      1 (2%)       1 (2%)       1 (2%)       2 (4%)                                
      Cytoplasmic Alteration, Focal                    3 (6%)                    1 (2%)       5 (10%)                               
      Hematopoietic Cell Proliferation                              1 (2%)                                                          
      Hemorrhage                                                    1 (2%)                                                          
      Hemorrhage, Focal                                             1 (2%)                                                          
      Vacuolization Cytoplasmic, Focal                 8 (16%)      3 (6%)       7 (14%)     12 (24%)                               
   Adrenal Medulla                                    (49)         (49)         (50)         (50)                                   
      Hyperplasia, Focal                               1 (2%)       1 (2%)       1 (2%)       2 (4%)                                
   Pituitary Gland                                    (50)         (48)         (50)         (50)                                   
      Angiectasis                                      5 (10%)      9 (19%)      7 (14%)      2 (4%)                                
      Cyst                                                          1 (2%)                                                          
      Hemorrhage                                                    1 (2%)                                                          
      Metaplasia, Focal, Lipocyte                                                1 (2%)                                             
      Pars Distalis, Angiectasis                                                              1 (2%)                                
      Pars Distalis, Cyst                              1 (2%)       3 (6%)       2 (4%)       1 (2%)                                
      Pars Distalis, Cyst, Multiple                                 2 (4%)                                                          
      Pars Distalis, Cytoplasmic Alteration, Focal     4 (8%)       4 (8%)       1 (2%)       3 (6%)                                
      Pars Distalis, Degeneration, Cystic              1 (2%)                                                                       
      Pars Distalis, Degeneration, Cystic, Focal       9 (18%)     14 (29%)      8 (16%)      5 (10%)                               
      Pars Distalis, Hemorrhage, Focal                 1 (2%)       3 (6%)       4 (8%)       6 (12%)                               
      Pars Distalis, Hyperplasia, Focal                1 (2%)       1 (2%)       1 (2%)       1 (2%)                                
      Pars Distalis, Pigmentation, Focal                                         1 (2%)                                             
      Pars Intermedia, Cyst                                                      1 (2%)       3 (6%)                                
      Pars Intermedia, Degeneration, Cystic, Focal                                            1 (2%)                                
      Pars Intermedia, Hemorrhage                                                             1 (2%)                                
      Pars Intermedia, Pars Nervosa, Atypia                                                                                         
        Cellular, Focal                                             1 (2%)                                                          
      Rathke's Cleft, Cyst                             1 (2%)                    1 (2%)                                             
      Rathke's Cleft, Hemorrhage                                                              2 (4%)                                
   Thyroid Gland                                      (49)         (48)         (42)         (48)                                   
      Vacuolization Cytoplasmic, Focal                              1 (2%)                                                          
      C-Cell, Hyperplasia                             48 (98%)     46 (96%)     40 (95%)     25 (52%)                               
      Follicle, Cyst                                                2 (4%)       1 (2%)                                             
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                             Page    4                                                              
                                                                                                                                   
NTP Experiment-Test: 92012-05         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: CHRONIC                                         2-METHYLIMIDAZOLE                                     Date: 03/14/03    
Route: DOSED FEED                                                                                                 Time: 10:29:56    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         FISCHER 344 RATS FEMALE                   0PPM         1000 PPM     2500 PPM     5000 PPM                                  
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ENDOCRINE SYSTEM - CONT                                                                                                             
      Follicle, Mineralization, Focal                 42 (86%)     47 (98%)     41 (98%)     48 (100%)                              
      Follicular Cell, Hyperplasia                                 41 (85%)     34 (81%)     46 (96%)                               
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENERAL BODY SYSTEM                                                                                                                
                                                                                                                                    
   Tissue NOS                                         (3)                       (4)          (2)                                    
      Mediastinum, Infiltration Cellular, Mixed                                                                                     
        Cell                                                                     1 (25%)                                            
      Pelvic, Hemorrhage, Focal                                                               1 (50%)                               
      Thoracic, Infiltration Cellular, Focal,                                                                                       
        Mixed Cell                                                               1 (25%)                                            
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENITAL SYSTEM                                                                                                                     
                                                                                                                                    
   Clitoral Gland                                     (50)         (49)         (50)         (50)                                   
      Degeneration, Cystic                             6 (12%)      4 (8%)       1 (2%)       1 (2%)                                
      Fibrosis, Focal                                               1 (2%)                                                          
      Hyperplasia, Cystic                              1 (2%)       4 (8%)       3 (6%)       1 (2%)                                
      Inflammation, Chronic                            2 (4%)       5 (10%)      4 (8%)                                             
   Ovary                                              (50)         (49)         (50)         (50)                                   
      Angiectasis                                      1 (2%)       1 (2%)                                                          
      Atrophy                                                       1 (2%)                                                          
      Congestion                                                                 1 (2%)                                             
      Cyst                                             5 (10%)      5 (10%)      1 (2%)                                             
      Bilateral, Cyst, Multiple                                                  1 (2%)                                             
      Periovarian Tissue, Cyst                         4 (8%)       5 (10%)      4 (8%)       6 (12%)                               
      Periovarian Tissue, Cyst, Multiple               1 (2%)                                                                       
   Uterus                                             (50)         (50)         (50)         (50)                                   
      Cyst                                             3 (6%)                    1 (2%)       1 (2%)                                
      Hemorrhage                                                                 2 (4%)                                             
      Inflammation, Chronic                                                      1 (2%)                                             
      Cervix, Hyperplasia                                                        1 (2%)                                             
      Endometrium, Hyperplasia, Cystic                10 (20%)     14 (28%)     15 (30%)     15 (30%)                               
   Vagina                                             (2)                       (2)                                                 
      Inflammation, Chronic                                                      1 (50%)                                            
      Epithelium, Cyst                                 1 (50%)                                                                      
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 HEMATOPOIETIC SYSTEM                                                                                                               
                                                                                                                                    
   Bone Marrow                                        (49)         (50)         (50)         (50)                                   
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                             Page    5                                                              
                                                                                                                                   
NTP Experiment-Test: 92012-05         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: CHRONIC                                         2-METHYLIMIDAZOLE                                     Date: 03/14/03    
Route: DOSED FEED                                                                                                 Time: 10:29:56    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         FISCHER 344 RATS FEMALE                   0PPM         1000 PPM     2500 PPM     5000 PPM                                  
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
HEMATOPOIETIC SYSTEM - CONT                                                                                                         
      Atrophy                                          1 (2%)                                                                       
      Fibrosis                                                                                1 (2%)                                
      Hyperplasia, Focal, Histiocytic                               1 (2%)                    4 (8%)                                
      Myelofibrosis                                                                           1 (2%)                                
      Necrosis                                                                                1 (2%)                                
      Myeloid Cell, Hyperplasia                        2 (4%)       3 (6%)       5 (10%)      2 (4%)                                
      Myeloid Cell, Erythroid Cell, Hyperplasia                     2 (4%)       1 (2%)                                             
   Lymph Node                                         (32)         (31)         (34)         (41)                                   
      Deep Cervical, Hemorrhage                                                               2 (5%)                                
      Mediastinal, Angiectasis                         1 (3%)                                                                       
      Mediastinal, Congestion                                                    1 (3%)                                             
      Mediastinal, Ectasia                             5 (16%)      3 (10%)      2 (6%)       7 (17%)                               
      Mediastinal, Hemorrhage                          2 (6%)       3 (10%)      9 (26%)      8 (20%)                               
      Mediastinal, Hyperplasia                                      1 (3%)       2 (6%)                                             
      Mediastinal, Hyperplasia, Histiocytic            8 (25%)      8 (26%)      5 (15%)     12 (29%)                               
      Mediastinal, Hyperplasia, Lymphoid                            1 (3%)       1 (3%)       1 (2%)                                
      Mediastinal, Pigmentation                        1 (3%)                    2 (6%)                                             
      Pancreatic, Atrophy                                           1 (3%)                                                          
      Pancreatic, Ectasia                              2 (6%)       2 (6%)                   11 (27%)                               
      Pancreatic, Hemorrhage                           5 (16%)      3 (10%)      2 (6%)       9 (22%)                               
      Pancreatic, Hyperplasia, Histiocytic            16 (50%)     24 (77%)     17 (50%)     18 (44%)                               
      Pancreatic, Hyperplasia, Plasma Cell             1 (3%)                                                                       
      Pancreatic, Infiltration Cellular, Mixed Cell                                           1 (2%)                                
      Pancreatic, Pigmentation                         4 (13%)      2 (6%)                    1 (2%)                                
   Lymph Node, Mandibular                             (5)          (4)          (5)          (1)                                    
      Ectasia                                          1 (20%)                                                                      
   Lymph Node, Mesenteric                             (49)         (49)         (49)         (50)                                   
      Angiectasis                                                                1 (2%)                                             
      Ectasia                                          1 (2%)                                 5 (10%)                               
      Hemorrhage                                       1 (2%)                    2 (4%)       2 (4%)                                
      Hyperplasia, Histiocytic                         2 (4%)       1 (2%)       2 (4%)       2 (4%)                                
      Hyperplasia, Lymphoid                                         1 (2%)                                                          
      Pigmentation                                     2 (4%)                                                                       
   Spleen                                             (50)         (49)         (48)         (50)                                   
      Accessory Spleen                                              1 (2%)       1 (2%)                                             
      Angiectasis, Focal                                            1 (2%)                                                          
      Congestion                                                    1 (2%)                                                          
      Fibrosis, Focal                                               1 (2%)       1 (2%)                                             
      Hematopoietic Cell Proliferation                 6 (12%)      8 (16%)      5 (10%)      4 (8%)                                
      Hemorrhage                                                                 1 (2%)                                             
      Infarct                                                                                 1 (2%)                                
      Inflammation, Granulomatous                      3 (6%)       2 (4%)       4 (8%)      27 (54%)                               
      Pigmentation                                                  1 (2%)                                                          
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                             Page    6                                                              
                                                                                                                                   
NTP Experiment-Test: 92012-05         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: CHRONIC                                         2-METHYLIMIDAZOLE                                     Date: 03/14/03    
Route: DOSED FEED                                                                                                 Time: 10:29:56    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         FISCHER 344 RATS FEMALE                   0PPM         1000 PPM     2500 PPM     5000 PPM                                  
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
HEMATOPOIETIC SYSTEM - CONT                                                                                                         
      Pigmentation, Focal                              1 (2%)       1 (2%)       1 (2%)                                             
   Thymus                                             (48)         (45)         (49)         (49)                                   
      Angiectasis                                                                2 (4%)                                             
      Hyperplasia, Lymphoid                            1 (2%)       1 (2%)                    2 (4%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 INTEGUMENTARY SYSTEM                                                                                                               
                                                                                                                                    
   Mammary Gland                                      (50)         (50)         (50)         (50)                                   
      Dilatation                                      33 (66%)     35 (70%)     22 (44%)     19 (38%)                               
      Ectasia                                          2 (4%)       3 (6%)       7 (14%)                                            
      Fibrosis                                                      1 (2%)                                                          
      Hyperplasia                                      3 (6%)       5 (10%)      4 (8%)       3 (6%)                                
      Hyperplasia, Cystic                              1 (2%)                    2 (4%)                                             
      Inflammation, Focal                                           1 (2%)                                                          
   Skin                                               (50)         (50)         (50)         (50)                                   
      Necrosis, Focal                                                                         4 (8%)                                
      Ulcer                                                                      1 (2%)       1 (2%)                                
      Subcutaneous Tissue, Angiectasis, Focal                                                 1 (2%)                                
      Subcutaneous Tissue, Hemorrhage, Focal                                                  1 (2%)                                
      Subcutaneous Tissue, Inflammation, Focal,                                                                                     
         Suppurative                                                                          1 (2%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 MUSCULOSKELETAL SYSTEM                                                                                                             
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 NERVOUS SYSTEM                                                                                                                     
                                                                                                                                    
   Brain                                              (50)         (49)         (50)         (50)                                   
      Compression, Focal                              10 (20%)      8 (16%)     12 (24%)      4 (8%)                                
      Hemorrhage, Focal                                2 (4%)       1 (2%)       2 (4%)                                             
      Necrosis, Focal                                                            2 (4%)                                             
      Pigmentation, Focal                                                        1 (2%)                                             
      Cerebellum, Developmental Malformation                                     1 (2%)                                             
   Spinal Cord                                        (3)          (1)          (4)                                                 
      Hemorrhage, Focal                                1 (33%)                                                                      
      Necrosis, Focal                                  1 (33%)                                                                      
____________________________________________________________________________________________________________________________________
                                                                                                                                    
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                                                                                                    
                                                             Page    7                                                              
                                                                                                                                   
NTP Experiment-Test: 92012-05         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: CHRONIC                                         2-METHYLIMIDAZOLE                                     Date: 03/14/03    
Route: DOSED FEED                                                                                                 Time: 10:29:56    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         FISCHER 344 RATS FEMALE                   0PPM         1000 PPM     2500 PPM     5000 PPM                                  
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 RESPIRATORY SYSTEM                                                                                                                 
                                                                                                                                    
   Lung                                               (50)         (49)         (50)         (50)                                   
      Congestion                                       2 (4%)       4 (8%)       2 (4%)       2 (4%)                                
      Emphysema                                                                  1 (2%)                                             
      Hemorrhage                                       1 (2%)                                                                       
      Hemorrhage, Focal                                1 (2%)                                 2 (4%)                                
      Hyperplasia, Focal, Histiocytic                                            1 (2%)       1 (2%)                                
      Hyperplasia, Histiocytic                         6 (12%)      6 (12%)      7 (14%)      1 (2%)                                
      Infiltration Cellular, Focal, Mixed Cell                                                1 (2%)                                
      Infiltration Cellular, Mixed Cell                             3 (6%)       1 (2%)       6 (12%)                               
      Inflammation, Chronic, Focal                     1 (2%)       2 (4%)       1 (2%)                                             
      Inflammation, Focal, Granulomatous               1 (2%)                                 1 (2%)                                
      Pigmentation, Focal                              1 (2%)                                                                       
      Alveolar Epithelium, Hyperplasia, Focal          7 (14%)      5 (10%)      3 (6%)       3 (6%)                                
      Alveolus, Inflammation, Focal, Granulomatous                                            1 (2%)                                
      Interstitium, Edema                                                        1 (2%)                                             
   Nose                                               (50)         (49)         (50)         (50)                                   
      Foreign Body                                                  1 (2%)                    1 (2%)                                
      Inflammation, Suppurative                        1 (2%)       1 (2%)                    2 (4%)                                
      Nasolacrimal Duct, Inflammation                  4 (8%)       2 (4%)       4 (8%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 SPECIAL SENSES SYSTEM                                                                                                              
                                                                                                                                    
   Eye                                                (50)         (49)         (49)         (50)                                   
      Atrophy                                          1 (2%)       1 (2%)       1 (2%)                                             
      Cataract                                         1 (2%)       2 (4%)       2 (4%)       1 (2%)                                
      Iris, Synechia                                                             1 (2%)                                             
      Retina, Degeneration                                          2 (4%)       1 (2%)       1 (2%)                                
   Harderian Gland                                    (50)         (49)         (50)         (50)                                   
      Hyperplasia, Cystic, Focal                       1 (2%)                                                                       
      Hyperplasia, Focal                               2 (4%)                    1 (2%)       1 (2%)                                
      Hyperplasia, Focal, Histiocytic                  1 (2%)       2 (4%)       1 (2%)       4 (8%)                                
      Inflammation, Chronic, Focal                                               3 (6%)       1 (2%)                                
      Inflammation, Focal, Granulomatous                                         1 (2%)                                             
      Epithelium, Hyperplasia, Focal                                2 (4%)       2 (4%)       1 (2%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 URINARY SYSTEM                                                                                                                     
                                                                                                                                    
   Kidney                                             (50)         (48)         (47)         (50)                                   
      Atrophy, Focal                                                2 (4%)       1 (2%)                                             
      Congestion                                                                 2 (4%)                                             
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                             Page    8                                                              
                                                                                                                                   
NTP Experiment-Test: 92012-05         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: CHRONIC                                         2-METHYLIMIDAZOLE                                     Date: 03/14/03    
Route: DOSED FEED                                                                                                 Time: 10:29:56    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         FISCHER 344 RATS FEMALE                   0PPM         1000 PPM     2500 PPM     5000 PPM                                  
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
URINARY SYSTEM - CONT                                                                                                               
      Cyst                                                                                    1 (2%)                                
      Infarct                                                                    1 (2%)                                             
      Nephropathy                                     38 (76%)     40 (83%)     38 (81%)     40 (80%)                               
      Glomerulus, Amyloid Deposition, Diffuse                                                 1 (2%)                                
      Pelvis, Inflammation                                                       1 (2%)                                             
      Renal Tubule, Accumulation, Hyaline Droplet     11 (22%)      7 (15%)      3 (6%)       4 (8%)                                
      Renal Tubule, Pigmentation                       8 (16%)      4 (8%)       5 (11%)                                            
   Urethra                                                                                   (2)                                    
      Transitional Epithelium, Hyperplasia, Diffuse                                           1 (50%)                               
   Urinary Bladder                                    (50)         (49)         (49)         (50)                                   
      Transitional Epithelium, Hyperplasia                                                    2 (4%)                                
                                                                                                                                    
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                             Page    9                                                              
                                                                                                                                   
NTP Experiment-Test: 92012-05         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: CHRONIC                                         2-METHYLIMIDAZOLE                                     Date: 03/14/03    
Route: DOSED FEED                                                                                                 Time: 10:29:56    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         FISCHER 344 RATS MALE                     0PPM         300 PPM      1000 PPM     3000 PPM                                  
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
DISPOSITION SUMMARY                                                                                                                 
                                                                                                                                    
  Animals Initially In Study                          60           60           60           60                                     
  Early Deaths                                                                                                                      
    Moribund Sacrifice                                13            6            7           13                                     
    Natural Death                                      2            4            7            2                                     
  Survivors                                                                                                                         
    Terminal Sacrifice                                34           39           35           35                                     
    Moribund Sacrifice                                 1                                                                            
    Natural Death                                                   1            1                                                  
                                                                                                                                    
  Animals Examined Microscopically                    50           50           50           50                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ALIMENTARY SYSTEM                                                                                                                  
                                                                                                                                    
   Intestine Large, Rectum                            (49)         (48)         (48)         (50)                                   
      Angiectasis, Focal                                                         1 (2%)                                             
   Liver                                              (50)         (50)         (50)         (50)                                   
      Angiectasis, Focal                                                         1 (2%)                                             
      Basophilic Focus                                23 (46%)     23 (46%)      8 (16%)      2 (4%)                                
      Cholangiofibrosis                                1 (2%)                                 1 (2%)                                
      Congestion                                                                 2 (4%)       1 (2%)                                
      Degeneration, Cystic, Focal                      4 (8%)       3 (6%)       2 (4%)       7 (14%)                               
      Eosinophilic Focus                               3 (6%)                    6 (12%)      1 (2%)                                
      Fibrosis, Focal                                                            1 (2%)                                             
      Hematopoietic Cell Proliferation                                                        2 (4%)                                
      Hepatodiaphragmatic Nodule                       6 (12%)      5 (10%)      4 (8%)       9 (18%)                               
      Hyperplasia, Focal, Lymphoid                     1 (2%)                    2 (4%)       1 (2%)                                
      Infiltration Cellular, Mixed Cell               25 (50%)     30 (60%)     27 (54%)     36 (72%)                               
      Inflammation, Granulomatous                     12 (24%)     11 (22%)      4 (8%)      11 (22%)                               
      Mixed Cell Focus                                14 (28%)     16 (32%)     23 (46%)     26 (52%)                               
      Necrosis, Focal                                  2 (4%)                    2 (4%)       1 (2%)                                
      Pigmentation, Focal                                                        2 (4%)                                             
      Bile Duct, Cyst                                                                         1 (2%)                                
      Bile Duct, Hyperplasia                          49 (98%)     49 (98%)     47 (94%)     49 (98%)                               
      Centrilobular, Congestion                                                  1 (2%)                                             
      Hepatocyte, Necrosis, Focal                      1 (2%)       1 (2%)       3 (6%)       2 (4%)                                
      Hepatocyte, Vacuolization Cytoplasmic,                                                                                        
        Diffuse                                                     1 (2%)                    1 (2%)                                
      Hepatocyte, Vacuolization Cytoplasmic, Focal    23 (46%)     30 (60%)     26 (52%)     23 (46%)                               
      Hepatocyte, Centrilobular, Necrosis                           2 (4%)       2 (4%)                                             
      Hepatocyte, Centrilobular, Vacuolization                                                                                      
        Cytoplasmic                                    5 (10%)      4 (8%)                    3 (6%)                                
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                             Page   10                                                              
                                                                                                                                   
NTP Experiment-Test: 92012-05         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: CHRONIC                                         2-METHYLIMIDAZOLE                                     Date: 03/14/03    
Route: DOSED FEED                                                                                                 Time: 10:29:56    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         FISCHER 344 RATS MALE                     0PPM         300 PPM      1000 PPM     3000 PPM                                  
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ALIMENTARY SYSTEM - CONT                                                                                                            
      Hepatocyte, Midzonal, Vacuolization                                                                                           
        Cytoplasmic                                    1 (2%)       1 (2%)       2 (4%)                                             
      Oval Cell, Hyperplasia                                                                  1 (2%)                                
      Serosa, Fibrosis, Focal                                       2 (4%)                                                          
   Mesentery                                          (26)         (46)         (35)         (20)                                   
      Fibrosis, Focal                                                                         1 (5%)                                
      Hemorrhage                                                                              2 (10%)                               
      Necrosis, Focal                                                                         1 (5%)                                
      Artery, Inflammation, Chronic                                                           1 (5%)                                
      Fat, Necrosis                                    1 (4%)       1 (2%)       2 (6%)                                             
      Fat, Necrosis, Focal                             8 (31%)     10 (22%)     16 (46%)     10 (50%)                               
   Pancreas                                           (49)         (49)         (50)         (50)                                   
      Atrophy, Diffuse                                                           1 (2%)                                             
      Atrophy, Focal                                                             1 (2%)       1 (2%)                                
      Fibrosis, Focal                                                                         1 (2%)                                
      Acinus, Atrophy, Diffuse                                      1 (2%)                    1 (2%)                                
      Acinus, Atrophy, Focal                          22 (45%)     27 (55%)     20 (40%)     36 (72%)                               
      Acinus, Hyperplasia, Focal                                                 1 (2%)                                             
      Duct, Cyst                                       1 (2%)                                                                       
      Duct, Cyst, Focal                                             1 (2%)                                                          
      Duct, Cyst, Focal, Multiple                      6 (12%)      2 (4%)       5 (10%)     12 (24%)                               
      Duct, Hyperplasia, Cystic                                     1 (2%)       1 (2%)                                             
      Duct, Hyperplasia, Cystic, Focal                              2 (4%)       3 (6%)                                             
      Duct, Hyperplasia, Focal                                      1 (2%)                                                          
   Salivary Glands                                    (50)         (50)         (50)         (50)                                   
      Atrophy, Focal                                                                          1 (2%)                                
      Inflammation, Chronic                                                                   1 (2%)                                
   Stomach, Forestomach                               (50)         (50)         (50)         (49)                                   
      Diverticulum                                     1 (2%)       1 (2%)       2 (4%)       1 (2%)                                
      Edema                                            1 (2%)                                                                       
      Erosion                                                       1 (2%)                    1 (2%)                                
      Inflammation, Focal                              1 (2%)                                 1 (2%)                                
      Ulcer                                            2 (4%)       1 (2%)       1 (2%)       4 (8%)                                
      Epithelium, Hyperplasia                          2 (4%)       3 (6%)                    6 (12%)                               
      Epithelium, Hyperplasia, Focal                                                          1 (2%)                                
      Serosa, Foreign Body                                                                    1 (2%)                                
      Serosa, Inflammation, Chronic, Focal                                                    1 (2%)                                
   Stomach, Glandular                                 (50)         (50)         (50)         (49)                                   
      Erosion                                          4 (8%)       1 (2%)       1 (2%)                                             
      Erosion, Focal                                   1 (2%)                    1 (2%)                                             
      Inflammation, Focal                              1 (2%)                                                                       
      Ulcer                                            2 (4%)                                                                       
      Epithelium, Necrosis, Focal                                                             1 (2%)                                
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                             Page   11                                                              
                                                                                                                                   
NTP Experiment-Test: 92012-05         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: CHRONIC                                         2-METHYLIMIDAZOLE                                     Date: 03/14/03    
Route: DOSED FEED                                                                                                 Time: 10:29:56    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         FISCHER 344 RATS MALE                     0PPM         300 PPM      1000 PPM     3000 PPM                                  
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ALIMENTARY SYSTEM - CONT                                                                                                            
      Glands, Hyperplasia, Cystic, Focal                            1 (2%)                                                          
      Glands, Hyperplasia, Focal                       1 (2%)                                                                       
   Tongue                                             (1)          (2)                       (1)                                    
      Epithelium, Hyperplasia, Focal                                                          1 (100%)                              
   Tooth                                              (1)          (1)          (1)          (2)                                    
      Malformation                                                  1 (100%)                                                        
      Peridontal Tissue, Inflammation                  1 (100%)                                                                     
      Peridontal Tissue, Inflammation, Chronic                                                1 (50%)                               
      Peridontal Tissue, Inflammation, Focal,                                                                                       
        Suppurative                                                              1 (100%)                                           
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 CARDIOVASCULAR SYSTEM                                                                                                              
                                                                                                                                    
   Heart                                              (50)         (50)         (50)         (50)                                   
      Cardiomyopathy                                   3 (6%)       5 (10%)     10 (20%)      5 (10%)                               
      Cardiomyopathy, Focal                                                      2 (4%)       1 (2%)                                
      Congestion                                                                 1 (2%)                                             
      Fibrosis                                                                                1 (2%)                                
      Infiltration Cellular, Mixed Cell                             1 (2%)                                                          
      Thrombosis                                       1 (2%)       1 (2%)                                                          
      Endocardium, Myocardium, Fibrosis, Focal         1 (2%)                                                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ENDOCRINE SYSTEM                                                                                                                   
                                                                                                                                    
   Adrenal Cortex                                     (50)         (50)         (50)         (50)                                   
      Accessory Adrenal Cortical Nodule                1 (2%)       4 (8%)       9 (18%)      5 (10%)                               
      Cytoplasmic Alteration, Focal                    2 (4%)       1 (2%)       1 (2%)       3 (6%)                                
      Degeneration, Cystic, Focal                                                1 (2%)                                             
      Hemorrhage                                       2 (4%)                                                                       
      Vacuolization Cytoplasmic, Focal                 6 (12%)      9 (18%)     10 (20%)     10 (20%)                               
   Adrenal Medulla                                    (50)         (50)         (50)         (50)                                   
      Angiectasis                                                   1 (2%)                                                          
      Hyperplasia                                      1 (2%)       1 (2%)                    1 (2%)                                
      Hyperplasia, Focal                               7 (14%)      5 (10%)      3 (6%)       7 (14%)                               
      Infiltration Cellular, Lymphoid                               1 (2%)                                                          
      Vacuolization Cytoplasmic, Focal                              1 (2%)                                                          
   Islets, Pancreatic                                 (50)         (49)         (50)         (50)                                   
      Atrophy                                                       1 (2%)                                                          
      Hyperplasia, Focal                                            2 (4%)       1 (2%)       1 (2%)                                
   Parathyroid Gland                                  (47)         (49)         (48)         (49)                                   
      Cyst                                                          1 (2%)                                                          
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                             Page   12                                                              
                                                                                                                                   
NTP Experiment-Test: 92012-05         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: CHRONIC                                         2-METHYLIMIDAZOLE                                     Date: 03/14/03    
Route: DOSED FEED                                                                                                 Time: 10:29:56    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         FISCHER 344 RATS MALE                     0PPM         300 PPM      1000 PPM     3000 PPM                                  
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ENDOCRINE SYSTEM - CONT                                                                                                             
      Hyperplasia                                                                             1 (2%)                                
      Hyperplasia, Focal                               1 (2%)                    1 (2%)                                             
      Bilateral, Hyperplasia, Focal                    1 (2%)                                                                       
   Pituitary Gland                                    (50)         (50)         (50)         (50)                                   
      Angiectasis                                      2 (4%)                    3 (6%)                                             
      Pars Distalis, Angiectasis                       3 (6%)       2 (4%)       2 (4%)       1 (2%)                                
      Pars Distalis, Cyst                              1 (2%)       4 (8%)       2 (4%)       3 (6%)                                
      Pars Distalis, Cytoplasmic Alteration, Focal     1 (2%)       4 (8%)       2 (4%)       5 (10%)                               
      Pars Distalis, Degeneration, Cystic, Focal       1 (2%)       1 (2%)       1 (2%)       1 (2%)                                
      Pars Distalis, Hyperplasia, Focal                2 (4%)       1 (2%)                    2 (4%)                                
      Pars Distalis, Inflammation, Chronic, Focal,                                                                                  
         Granulomatous                                                           1 (2%)                                             
      Pars Distalis, Pars Intermedia, Angiectasis                   1 (2%)                                                          
      Pars Intermedia, Cyst                                         2 (4%)                    1 (2%)                                
      Pars Intermedia, Hemorrhage                                                1 (2%)                                             
      Pars Intermedia, Hyperplasia, Focal                           1 (2%)                                                          
      Pars Nervosa, Infiltration Cellular, Focal,                                                                                   
         Mixed Cell                                                              1 (2%)                                             
   Thyroid Gland                                      (48)         (46)         (43)         (50)                                   
      Cyst                                                          1 (2%)                                                          
      C-Cell, Hyperplasia                             41 (85%)     43 (93%)     38 (88%)     34 (68%)                               
      Follicle, Cyst                                   1 (2%)                                 1 (2%)                                
      Follicle, Mineralization, Focal                 48 (100%)    45 (98%)     43 (100%)    49 (98%)                               
      Follicular Cell, Atrophy, Focal                  1 (2%)                                                                       
      Follicular Cell, Hyperplasia                                 17 (37%)     37 (86%)     43 (86%)                               
      Follicular Cell, Hyperplasia, Cystic, Focal      1 (2%)                                 1 (2%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENERAL BODY SYSTEM                                                                                                                
                                                                                                                                    
   Tissue NOS                                         (7)          (2)          (6)          (4)                                    
      Mediastinum, Hemorrhage                                                                 1 (25%)                               
      Thoracic, Hemorrhage                                                                    1 (25%)                               
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENITAL SYSTEM                                                                                                                     
                                                                                                                                    
   Epididymis                                         (50)         (50)         (50)         (50)                                   
      Atrophy                                                       1 (2%)                    1 (2%)                                
      Granuloma Sperm                                               1 (2%)       1 (2%)       1 (2%)                                
      Inflammation, Chronic                                         1 (2%)       1 (2%)                                             
   Preputial Gland                                    (50)         (50)         (50)         (50)                                   
      Cyst                                             1 (2%)                                                                       
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                             Page   13                                                              
                                                                                                                                   
NTP Experiment-Test: 92012-05         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: CHRONIC                                         2-METHYLIMIDAZOLE                                     Date: 03/14/03    
Route: DOSED FEED                                                                                                 Time: 10:29:56    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         FISCHER 344 RATS MALE                     0PPM         300 PPM      1000 PPM     3000 PPM                                  
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
GENITAL SYSTEM - CONT                                                                                                               
      Degeneration, Cystic                                                                    2 (4%)                                
      Hyperplasia                                                                1 (2%)                                             
      Hyperplasia, Cystic                              2 (4%)                    2 (4%)       1 (2%)                                
      Hyperplasia, Focal                               1 (2%)                                                                       
      Inflammation, Chronic                            4 (8%)      10 (20%)     10 (20%)     11 (22%)                               
      Inflammation, Chronic, Focal                                  1 (2%)                                                          
      Inflammation, Suppurative                                     1 (2%)       1 (2%)       2 (4%)                                
   Prostate                                           (50)         (50)         (50)         (50)                                   
      Atrophy                                          1 (2%)                                                                       
      Hyperplasia, Focal                                            1 (2%)                                                          
      Inflammation, Chronic                           15 (30%)     10 (20%)     17 (34%)     19 (38%)                               
      Epithelium, Degeneration, Focal, Mucoid          1 (2%)                                                                       
      Epithelium, Hyperplasia, Focal                   4 (8%)       2 (4%)                    5 (10%)                               
   Testes                                             (50)         (50)         (50)         (50)                                   
      Atrophy                                          5 (10%)      4 (8%)      13 (26%)     13 (26%)                               
      Mineralization, Focal                            1 (2%)                                                                       
      Bilateral, Atrophy                               2 (4%)       3 (6%)       2 (4%)                                             
      Bilateral, Interstitial Cell, Hyperplasia,                                                                                    
         Focal                                                                                2 (4%)                                
      Germinal Epithelium, Atrophy                     2 (4%)       3 (6%)       1 (2%)       1 (2%)                                
      Interstitial Cell, Hyperplasia                                2 (4%)       1 (2%)       1 (2%)                                
      Interstitial Cell, Hyperplasia, Focal            1 (2%)       4 (8%)       4 (8%)       9 (18%)                               
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 HEMATOPOIETIC SYSTEM                                                                                                               
                                                                                                                                    
   Bone Marrow                                        (50)         (50)         (47)         (50)                                   
      Fibrosis                                                                   1 (2%)                                             
      Hyperplasia                                                   1 (2%)                                                          
      Hyperplasia, Focal, Histiocytic                               1 (2%)       1 (2%)                                             
      Myeloid Cell, Hyperplasia                                     1 (2%)                    5 (10%)                               
   Lymph Node                                         (39)         (49)         (42)         (38)                                   
      Hemorrhage                                                                              1 (3%)                                
      Hyperplasia, Lymphoid                                                      1 (2%)                                             
      Mediastinal, Angiectasis                                      1 (2%)                                                          
      Mediastinal, Congestion                                                    1 (2%)                                             
      Mediastinal, Ectasia                             1 (3%)                    3 (7%)       1 (3%)                                
      Mediastinal, Hemorrhage                          1 (3%)       1 (2%)       5 (12%)      1 (3%)                                
      Mediastinal, Hyperplasia, Histiocytic            2 (5%)       1 (2%)                    4 (11%)                               
      Mediastinal, Hyperplasia, Lymphoid               1 (3%)       1 (2%)       1 (2%)       1 (3%)                                
      Mediastinal, Pigmentation                                     1 (2%)                    1 (3%)                                
      Pancreatic, Angiectasis                          1 (3%)                                 1 (3%)                                
      Pancreatic, Ectasia                              1 (3%)       3 (6%)       3 (7%)       2 (5%)                                
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                             Page   14                                                              
                                                                                                                                   
NTP Experiment-Test: 92012-05         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: CHRONIC                                         2-METHYLIMIDAZOLE                                     Date: 03/14/03    
Route: DOSED FEED                                                                                                 Time: 10:29:56    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         FISCHER 344 RATS MALE                     0PPM         300 PPM      1000 PPM     3000 PPM                                  
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
HEMATOPOIETIC SYSTEM - CONT                                                                                                         
      Pancreatic, Hemorrhage                           1 (3%)                    1 (2%)       4 (11%)                               
      Pancreatic, Hyperplasia, Focal, Histiocytic      1 (3%)                                                                       
      Pancreatic, Hyperplasia, Histiocytic            13 (33%)     12 (24%)     15 (36%)     19 (50%)                               
      Pancreatic, Hyperplasia, Lymphoid                                          1 (2%)       1 (3%)                                
      Pancreatic, Pigmentation                         1 (3%)                                 1 (3%)                                
   Lymph Node, Mandibular                             (2)          (1)          (2)          (2)                                    
      Hyperplasia, Plasma Cell                                                   1 (50%)                                            
   Lymph Node, Mesenteric                             (47)         (50)         (50)         (50)                                   
      Ectasia                                                       2 (4%)                    2 (4%)                                
      Hemorrhage                                                                 1 (2%)       1 (2%)                                
      Hyperplasia, Histiocytic                         1 (2%)       2 (4%)       1 (2%)       4 (8%)                                
      Hyperplasia, Lymphoid                            2 (4%)       1 (2%)                                                          
   Spleen                                             (49)         (49)         (50)         (50)                                   
      Angiectasis, Focal                               1 (2%)                    1 (2%)                                             
      Congestion                                                                              1 (2%)                                
      Cyst                                                          1 (2%)                                                          
      Fibrosis, Focal                                  2 (4%)                    2 (4%)       1 (2%)                                
      Hematopoietic Cell Proliferation                 4 (8%)       4 (8%)       1 (2%)       6 (12%)                               
      Hemorrhage                                                                 1 (2%)                                             
      Hemorrhage, Focal                                                                       1 (2%)                                
      Hyperplasia, Lymphoid                                         1 (2%)       2 (4%)                                             
      Infarct                                          1 (2%)       1 (2%)                                                          
      Inflammation, Granulomatous                                                2 (4%)       3 (6%)                                
      Necrosis, Focal                                  1 (2%)                    1 (2%)       1 (2%)                                
      Pigmentation                                                               1 (2%)                                             
      Capsule, Fibrosis, Focal                         1 (2%)                                                                       
   Thymus                                             (48)         (48)         (44)         (49)                                   
      Atrophy                                          1 (2%)       1 (2%)                                                          
      Cyst, Multiple                                   1 (2%)                                                                       
      Hemorrhage                                       1 (2%)                                 1 (2%)                                
      Hyperplasia, Lymphoid                            2 (4%)       1 (2%)       1 (2%)                                             
      Epithelial Cell, Cyst, Multiple                               1 (2%)                                                          
      Epithelial Cell, Hyperplasia                     1 (2%)                                                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 INTEGUMENTARY SYSTEM                                                                                                               
                                                                                                                                    
   Mammary Gland                                      (48)         (47)         (45)         (42)                                   
      Dilatation                                       7 (15%)      1 (2%)       3 (7%)       2 (5%)                                
      Ectasia                                                                    1 (2%)                                             
      Hyperplasia                                      2 (4%)                                                                       
      Hyperplasia, Cystic                                                                     1 (2%)                                
      Epithelium, Pigmentation                                      1 (2%)                                                          
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                             Page   15                                                              
                                                                                                                                   
NTP Experiment-Test: 92012-05         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: CHRONIC                                         2-METHYLIMIDAZOLE                                     Date: 03/14/03    
Route: DOSED FEED                                                                                                 Time: 10:29:56    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         FISCHER 344 RATS MALE                     0PPM         300 PPM      1000 PPM     3000 PPM                                  
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
INTEGUMENTARY SYSTEM - CONT                                                                                                         
   Skin                                               (50)         (50)         (50)         (50)                                   
      Angiectasis, Focal                                            1 (2%)                                                          
      Cyst Epithelial Inclusion                                                  1 (2%)       1 (2%)                                
      Fibrosis, Focal                                  1 (2%)                                                                       
      Hemorrhage, Focal                                1 (2%)                                 1 (2%)                                
      Inflammation, Chronic, Focal                     1 (2%)                    1 (2%)       1 (2%)                                
      Necrosis, Focal                                                                         1 (2%)                                
      Pinna, Necrosis, Focal                           1 (2%)                                                                       
      Subcutaneous Tissue, Angiectasis, Focal                                                 1 (2%)                                
      Subcutaneous Tissue, Cyst                                                               1 (2%)                                
      Subcutaneous Tissue, Foreign Body                                                       1 (2%)                                
      Subcutaneous Tissue, Hemorrhage, Focal                                                  1 (2%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 MUSCULOSKELETAL SYSTEM                                                                                                             
                                                                                                                                    
   Skeletal Muscle                                    (2)          (1)          (1)          (4)                                    
      Fibrosis, Focal                                                                         1 (25%)                               
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 NERVOUS SYSTEM                                                                                                                     
                                                                                                                                    
   Brain                                              (50)         (50)         (50)         (50)                                   
      Compression, Focal                               4 (8%)       2 (4%)       4 (8%)       1 (2%)                                
      Hemorrhage, Focal                                2 (4%)       3 (6%)       2 (4%)       1 (2%)                                
      Necrosis, Focal                                  1 (2%)       1 (2%)                                                          
   Spinal Cord                                        (1)                       (1)                                                 
      Hemorrhage, Focal                                                          1 (100%)                                           
      Mineralization, Focal                                                      1 (100%)                                           
      Necrosis, Focal                                                            1 (100%)                                           
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 RESPIRATORY SYSTEM                                                                                                                 
                                                                                                                                    
   Larynx                                                                       (1)          (1)                                    
      Glands, Hyperplasia, Focal                                                              1 (100%)                              
   Lung                                               (50)         (50)         (50)         (50)                                   
      Congestion                                       1 (2%)                    1 (2%)       1 (2%)                                
      Hemorrhage, Focal                                1 (2%)                    1 (2%)       1 (2%)                                
      Hyperplasia, Focal, Histiocytic                  4 (8%)       1 (2%)                                                          
      Hyperplasia, Histiocytic                         3 (6%)       3 (6%)       2 (4%)       2 (4%)                                
      Infiltration Cellular, Focal, Mixed Cell                                                1 (2%)                                
      Infiltration Cellular, Mixed Cell                2 (4%)       1 (2%)       1 (2%)                                             
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                             Page   16                                                              
                                                                                                                                   
NTP Experiment-Test: 92012-05         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: CHRONIC                                         2-METHYLIMIDAZOLE                                     Date: 03/14/03    
Route: DOSED FEED                                                                                                 Time: 10:29:56    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         FISCHER 344 RATS MALE                     0PPM         300 PPM      1000 PPM     3000 PPM                                  
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
RESPIRATORY SYSTEM - CONT                                                                                                           
      Inflammation, Focal                                                                     1 (2%)                                
      Metaplasia, Focal, Osseous                                    2 (4%)       1 (2%)       2 (4%)                                
      Metaplasia, Osseous                                                                     2 (4%)                                
      Alveolar Epithelium, Hyperplasia, Focal          2 (4%)       9 (18%)      6 (12%)      5 (10%)                               
      Alveolus, Foreign Body, Focal                                                           1 (2%)                                
      Interstitium, Edema                                                        1 (2%)       1 (2%)                                
   Nose                                               (50)         (50)         (50)         (50)                                   
      Foreign Body                                     1 (2%)                                                                       
      Inflammation, Suppurative                        2 (4%)                    1 (2%)                                             
      Nasolacrimal Duct, Inflammation                               2 (4%)       1 (2%)       2 (4%)                                
      Nasolacrimal Duct, Inflammation, Chronic                      1 (2%)                                                          
      Nasolacrimal Duct, Inflammation, Suppurative                  3 (6%)                                                          
      Sinus, Foreign Body                                           1 (2%)                                                          
      Sinus, Inflammation, Suppurative                              1 (2%)                                                          
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 SPECIAL SENSES SYSTEM                                                                                                              
                                                                                                                                    
   Eye                                                (49)         (50)         (46)         (50)                                   
      Atrophy                                                       1 (2%)                                                          
      Cataract                                         1 (2%)                    1 (2%)                                             
      Synechia                                                                   1 (2%)                                             
      Cornea, Inflammation, Focal                                   1 (2%)                                                          
      Cornea, Necrosis, Focal                                       1 (2%)                                                          
      Iris, Hyperplasia                                1 (2%)                                                                       
      Lens, Cataract                                                1 (2%)                                                          
      Retina, Degeneration                                                       1 (2%)                                             
      Retrobulbar, Inflammation, Focal                              1 (2%)                                                          
   Harderian Gland                                    (50)         (50)         (49)         (50)                                   
      Hyperplasia, Focal                                            1 (2%)                    2 (4%)                                
      Hyperplasia, Focal, Histiocytic                                                         1 (2%)                                
      Hyperplasia, Histiocytic                                                   1 (2%)                                             
      Inflammation, Chronic, Focal                     1 (2%)                    2 (4%)       3 (6%)                                
      Inflammation, Focal, Granulomatous                                                      1 (2%)                                
      Epithelium, Hyperplasia, Focal                   3 (6%)                                 1 (2%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 URINARY SYSTEM                                                                                                                     
                                                                                                                                    
   Kidney                                             (49)         (49)         (49)         (50)                                   
      Accumulation, Hyaline Droplet                    1 (2%)                                                                       
      Atrophy, Focal                                                                          1 (2%)                                
      Congestion                                       1 (2%)       1 (2%)                                                          
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                             Page   17                                                              
                                                                                                                                   
NTP Experiment-Test: 92012-05         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: CHRONIC                                         2-METHYLIMIDAZOLE                                     Date: 03/14/03    
Route: DOSED FEED                                                                                                 Time: 10:29:56    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         FISCHER 344 RATS MALE                     0PPM         300 PPM      1000 PPM     3000 PPM                                  
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
URINARY SYSTEM - CONT                                                                                                               
      Cyst                                                          2 (4%)                    2 (4%)                                
      Fibrosis, Focal                                                                         1 (2%)                                
      Infarct                                                       1 (2%)                                                          
      Inflammation                                     1 (2%)                                                                       
      Nephropathy                                     43 (88%)     43 (88%)     41 (84%)     46 (92%)                               
      Pelvis, Inflammation, Chronic                                              1 (2%)                                             
      Pelvis, Transitional Epithelium, Hyperplasia                               1 (2%)                                             
      Renal Tubule, Accumulation, Hyaline Droplet      1 (2%)       1 (2%)       3 (6%)       2 (4%)                                
      Renal Tubule, Necrosis, Focal                    1 (2%)                                                                       
      Renal Tubule, Pigmentation                       5 (10%)      3 (6%)       2 (4%)       3 (6%)                                
   Urinary Bladder                                    (50)         (50)         (49)         (50)                                   
      Hemorrhage                                                                 1 (2%)                                             
                                                                                                                                    
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                             Page   18                                                              
                                                                                                                                   
                             ------------------------------------------------------------                                           
                             ----------              END OF REPORT             ----------                                           
                             ------------------------------------------------------------